Functional echocardiography in staging for ductal disease severity: Role in predicting outcomes

European Journal of Pediatrics

Volumn 172, Issue 2, 2013, Pages 179-184

  Sehgal, Arvind ^a,b   Paul, Eldho ^b   Menahem, Samuel ^b,c  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SOUTHERN HEALTH   (Australia)

Author keywords

Chronic lung disease; Ductus arteriosus; Echocardiography; Staging

Indexed keywords

IBUPROFEN; STEROID;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ASSESSMENT; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; GESTATIONAL AGE; HUMAN; INFANT; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PATENT DUCTUS ARTERIOSUS; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; RESPIRATION DISORDERS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84877115043     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-012-1851-0     Document Type: Article

References (25)

1. Benitz WE (2010) Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30:241-252
2. Bose CL, Laughon MM (2007) Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 92:F498-F502
3. Carmo KB, Evans N, Paradisis M (2009) Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography. J Pediatr 155(6):819.e1-822.e1
4. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419-F422
5. El-Khuffash AF, Slevin M, McNamara PJ, Molloy EJ (2011) Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed 96:F133-F137
6. Evans N, Iyer P (1995) Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 72:F156-F161
7. Evans N (1993) Diagnosis of patent ductus arteriosus in the preterm newborn. Arch Dis Child 68:58-61
8. Evans N (2003) Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 3:168-177
9. Harling S, Hansen-Pupp I, Biagi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. acta Paediatr. 2011; 100: 231-235.
10. Hirashi S, Horiguchi Y, Misawa H, Oguchi K, Kadoi N, Fujino N, Yashiro K (1987) Noninvasive Doppler echocardiographic evaluation of shunt flow haemodynamics of the ductus arteriosus. Circulation 75:1146-1153
11. Jain A, Sahni M, El-Khuffash E, Khadawardi E, Sehgal A, McNamara PJ (2011) Use of Targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus ateriosus ligation. J Pediatr. Nov 1. [Epub ahead of print]
12. Johnson GL, Breart GL, Gewitz MH, Brenner JI, Lang P, Dooley KJ, Ellison RC (1983) Echocardiographic characteristics of premature infants with patent ductus arteriosus. Pediatrics 72:864-871
13. Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774-779
14. Kluckow M, Gill A, Jeffery M, Evans N (2012) Ductal Echocardiographic Targeting and Early Closure Trial (DETECT): a pilot randomised controlled trial. Pediatric Academic Societies Annual Meeting E-PAS 1675.5.
15. Knight DB (2001) The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 6:63-73
16. Kupfershmid C, Lang D, Pohlandt F (1988) Sensitivity, specificity and predictive value of clinical findings. M-mode echocardiography and continuous wave Doppler sonography in the diagnosis of symptomatic patent ductus arteriosus in preterm infants. Eur J Pediatr 147:279-282
17. Laughon MM, Simmons MA, Bose CL (2004) Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 16:146-151
18. Ramos FG, Rosenfeld CR, Roy L, Koch J, Ramaciotti C (2010) Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates. J Perinatol 30:535-539
19. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL, Trial of Indomethacin Prophylaxis in Preterms Investigators (2001) Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344(26):1966-1972
20. Sehgal A, McNamara PJ (2009) Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus. Eur J Pediatr 168:907-914
21. Sehgal A, McNamara PJ (2010) Staging the ductus arteriosus facilitates identification of neonates at increased risk of respiratory morbidity. J Neonatal Perinatal Med 4:14-17
22. Sehgal A, McNamara PJ (2008) Does point-of-care functional echocardiography enhance cardiovascular care in the NICU? J Perinatol 28:729-735
23. Shah SS, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 1:CD004213
24. Suzumura H, Nitta A, Tanaka G, Arisaka O (2001) Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int 43:146-151
25. Van Overmeire B, Chemtob S (2005) The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 10:177-184